康桥资本 Mediaroom - PR Newswire APAC

Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan

TOKYO, June 20, 2023 /PRNewswire/ -- Jadeite Medicines Inc., (Jadeite Medicines) a clinical stage b...

2023-06-21 09:00 2858

CBC GROUP RELEASES 2022 ESG REPORT

Guided by the firm's commitment to drive positive and meaningful impact while delivering better he...

2023-06-01 10:00 2389

Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®

The acquisition will deliver strong commercial synergy with Hasten's current critical care portfoli...

2023-05-04 14:00 2167

CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA

Proceeds raised will be used to fund future acquisitions, and fuel business development of innovati...

2023-04-20 13:00 2254

CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner

SINGAPORE, March 31, 2023 /PRNewswire/ -- Singapore-headquartered asset management firm, CBC Group ...

2023-04-01 10:00 3745

RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

BOSTON, March 17, 2023 /PRNewswire/ -- RVAC Medicines (US), Inc., a messenger RNA (mRNA) technology...

2023-03-17 21:00 3894

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

SINGAPORE, Feb. 20, 2023 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) te...

2023-02-21 10:00 1968

CBC Group Appoints Chief Operating Officer, Strengthening the Firm's Global Operational Capabilities

The former BlackRock and Goldman Sachs executive will oversee the firm's business management functi...

2023-02-01 20:18 2116

Navigating a perfect storm - driving access to healthcare in emerging markets

* Healthcare demand and expenditure in Southeast Asia are set to increase rapidly amidst rising a...

2022-11-30 15:00 1655

RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR mRNA PRODUCTION IN SINGAPORE

SINGAPORE, Nov. 20, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) te...

2022-11-21 10:00 2313

CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO

WALTHAM, Mass., Nov. 10, 2022 /PRNewswire/ -- ABio-X, the Massachusetts-based biotech incubation p...

2022-11-10 21:00 2541

CBC Healthcare Infrastructure Platform acquires prime industrial land in Shanghai to develop a high-specifications life science park

* 83.76 mu plot within the Life Science zone of the Qingpu Industrial Park, Shanghai Development ...

2022-11-01 11:00 1898

RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates

SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd., a messenger RNA (mRNA) technolo...

2022-09-22 10:00 1645

CBC Welcomes Former Allergan CEO Brent Saunders to Join Hugel Board as Executive Chair

* Saunders brings decades of healthcare leadership experience, and plans to propel Korea's #1 med...

2022-05-20 15:00 2059

RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity

Series B financing led by CBC with participation from Temasek's Pavilion Capital, EDBI and GS Holdi...

2022-04-27 10:00 1936

ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets

BOSTON, April 6, 2022 /PRNewswire/ -- ENSEM Therapeutics Inc. (ENSEM), a Boston -based biotechnology...

2022-04-07 04:00 1916

CBC Group-backed Hasten Biopharma successfully completes acquisition of five cardiovascular and metabolism drugs from Takeda

* CBC Group continues to expand its global healthcare ecosystem to fulfil unmet medical needs *...

2022-03-31 15:05 1743

Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets

* Bavarian Nordic to receive up to USD 225 million in upfront and milestone payments in addition ...

2022-03-21 16:20 1647

Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Nuance Pharma ("Nuance"or the "Company"), a specialty care f...

2022-01-06 14:45 2810

Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China

SHANGHAI, Dec. 22, 2021 /PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatment...

2021-12-23 07:44 2287

Latest News